Non classé FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease. By Becky Upham July 22, 2022 On July 18, the U.S. Food and Drug Administration…Thando Ngwenya27 July 2022
Newsletter 3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS) 50 attendees - 20 nations 20 leaders of vitiligo organizations from all over the world,…Thando Ngwenya9 June 2022
